delta sleep-inducing peptide has been researched along with Kidney Failure, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekman, R; Hegbrant, J; Thysell, H | 1 |
1 other study(ies) available for delta sleep-inducing peptide and Kidney Failure, Chronic
| Article | Year |
|---|---|
Erythropoietin treatment and plasma levels of corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients.
Topics: Adult; Aged; alpha-MSH; beta-Endorphin; beta-Lipotropin; Corticotropin-Releasing Hormone; Delta Sleep-Inducing Peptide; Endorphins; Enkephalin, Methionine; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Recombinant Proteins; Renal Dialysis | 1992 |